| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/22/2009 | EP2049117A2 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2009 | EP1425266B1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 04/22/2009 | CN101415689A Substituted quinazolines with anti-cancer activity |
| 04/22/2009 | CN101415688A Quinazolone derivative with B-RAF inhibition activity |
| 04/22/2009 | CN101415683A New compounds |
| 04/22/2009 | CN101415422A Anti-cancer pharmaceutical composition |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/21/2009 | US7521555 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines; (pyrimidine-2-yl)-2-propanonee compound reacted with hydrazine compound in the presence of an acid to produce indole compound, oxidizing, reducing, deacetylation |
| 04/21/2009 | US7521554 A2B adenosine receptor antagonists |
| 04/21/2009 | US7521457 Pyrimidines as PLK inhibitors |
| 04/21/2009 | US7521456 Antiproliferative agents; anticancer agents; Erlotinib mesylate |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521452 Preparation of pharmaceutical salts of piperazine compounds |
| 04/21/2009 | US7521451 e.g. 5,6-dimethyl-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione;intravenous, water-soluble compounds useful for manufacturing an anasthetic, sedative agents; side effect reduction |
| 04/21/2009 | US7521446 4-({8-[(2,6-Difluorophenyl)amino]-9-cyclopentylpurin-2-yl}amino) trans-cyclohexan-1-ol; mitogen-activated protein (tyrosine) kinase inhibitor; anticarcinogenic, antiinflammatory, analgesic agent, cardiovascular disease, renal disease, autoimmune condition, macular degeneration, pulmonary hypertension |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521396 processes for their preparation, and to their use as herbicides. |
| 04/21/2009 | US7521175 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571 |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/16/2009 | WO2009048752A2 Insecticidal substituted azinyl derivatives |
| 04/16/2009 | WO2009048751A1 Insecticidal pyrimidinyl aryl hydrazones |
| 04/16/2009 | WO2009047577A1 Process for preparation of rosuvastatin zinc salt |
| 04/16/2009 | WO2009047576A1 Process for preparation of pharmaceutical intermediates |
| 04/16/2009 | WO2009047359A1 Inhibitors of protein kinases |
| 04/16/2009 | WO2009047255A1 Heterobicyclic compounds as histamine h4-receptor antagonists |
| 04/16/2009 | WO2009047043A1 Co-crystals of pyrimethanil and dithianon |
| 04/16/2009 | WO2009046606A1 Pyrimidinyl-propionic acid derivatives and their use as ppar agonists |
| 04/16/2009 | WO2009002538A3 Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib |
| 04/16/2009 | WO2008145052A9 Substituted pyrimidine ether compounds and their use |
| 04/16/2009 | WO2007138613A3 A process for synthesis of [6,7-bis-(2-methoxyethoxy)-quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride |
| 04/16/2009 | WO2007138612A3 A process for synthesis of [6,7-bis-(2-methoxyethoxy)-quinazolin-4- yl]-(3-ethynylphenyl)amine hydrochloride |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099220 Antimalarial compounds with flexible side-chains |
| 04/16/2009 | US20090099219 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/16/2009 | US20090099218 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 04/16/2009 | US20090099217 2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies |
| 04/16/2009 | US20090099208 Novel guanidine derivatives and their medical use |
| 04/16/2009 | US20090099206 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | US20090099204 Amide derivative, insecticide containing the same and method for application thereof as insecticide |
| 04/16/2009 | US20090099190 Kinase inhibitors useful for the treatment of proliferative diseases |
| 04/16/2009 | US20090099183 Pyrimidines and uses thereof |
| 04/16/2009 | CA2702008A1 Inhibitors of protein kinases |
| 04/16/2009 | CA2701904A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | CA2700880A1 Antimalarial compounds with flexible side-chains |
| 04/16/2009 | CA2696685A1 Co-crystals of pyrimethanil and dithianon |
| 04/15/2009 | EP2048141A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 04/15/2009 | EP2046759A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 04/15/2009 | EP2046758A1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | EP1663989B1 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT |
| 04/15/2009 | EP1660091B1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/15/2009 | CN101410394A HIV inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines |
| 04/15/2009 | CN101410375A Method for producing aromatic compound |
| 04/15/2009 | CN101407498A Process for the preparation of pyrimidine compounds |
| 04/15/2009 | CN101407497A Method for preparing rosuvastatin calcium intermediate |
| 04/15/2009 | CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN100478343C Purine compound and use as cannabinoid receptor ligands |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517913 ribozyme ribonuclease P, interleukin-2 and interferon- gamma inhibitors; for neoplastic, keratinization and inflammatory disorders; N1,N12-Bisretinoylspermine; condensation of polyamines or suitably protected derivatives with vitamin A derivatives |
| 04/14/2009 | US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 04/14/2009 | US7517889 2-(3-{6-[2-(2,4-dichloro-phenyl)-ethylamino]-2-methoxy-pyrimidin-4-yl}-phenyl)-2-methyl-propionic acid; allergic disease; systemic mastocytosis, disorders accompanied by systemic mast cell activation, anaphylaxis shock, bronchoconstriction, bronchitis, urticaria, eczema, diseases accompanied by itch |
| 04/14/2009 | CA2417050C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2385863C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 04/14/2009 | CA2371789C Novel guanidine derivatives as inhibitors of cell adhesion |
| 04/09/2009 | WO2009046090A1 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3- alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044018A2 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/09/2009 | WO2009017777A3 Metabolites and derivatives of ambrisentan |
| 04/09/2009 | WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 04/09/2009 | WO2008074578A3 Agent for dyeing fibers comprising keratin |
| 04/09/2009 | WO2008050168A8 New sulfonamide derivatives as bradykinin antagonists |
| 04/09/2009 | US20090093494 4-Pyrimidineamine Compounds And Uses As Anti-Proliferative Agents |
| 04/09/2009 | US20090093490 Heterocyclylethylbenzamide derivatives |
| 04/09/2009 | US20090093486 Insecticidal substituted azinyl derivatives |
| 04/09/2009 | US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases |
| 04/09/2009 | US20090093480 Insecticidal pyrimidinyl aryl hyrdrazones |
| 04/09/2009 | US20090090628 Nucleic acid derivatives and methods of use |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2699598A1 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 04/09/2009 | CA2694313A1 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/08/2009 | EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 04/08/2009 | EP2044037A2 Hiv reverse transcriptase inhibitors |
| 04/08/2009 | EP2044036A1 [4,5']bipyrimidinyl-6,4'-diamine derivatives as protein kinase inhbitors |
| 04/08/2009 | EP2044027A2 Fused bicyclic compounds interacting with the histamine h4 receptor |
| 04/08/2009 | EP2044026A1 Method of treatment of glioma brain tumour |
| 04/08/2009 | EP2044004A2 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 04/08/2009 | EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/08/2009 | EP1673352B1 Sulfoximine-substituted pyrimidines for use as cd and/or vegf-inhibitors, the production thereof and their use as drugs |
| 04/08/2009 | CN101405266A Piperazines and piperidines as mGlur5 potentiators |
| 04/08/2009 | CN101402611A Compound with anti-leukocythemia liveness and method of preparing the same |
| 04/08/2009 | CN101402610A Synthesis method of 4-(3-chlorine-4-fluorobenzene amino)-7-methoxy-6-[3-(4-morpholinyl)-propoxy] quinoline |